Our Products & Technologies Target 3 Markets:

Reversal & Recovery:
USD $3.02B by 20251
Fortified Foods & Nutraceuticals:
USD $722B by 20272
Psychedelics:
USD $6.86B by 20273
1. https://www.forbes.com/sites/douglasyu/2021/02/16/booming-demand-for-hangover-prevention-and-hydration-products-pushes-canadian-startup-no-days-wasted-into-retail/; 2. https://www.grandviewresearch.com/press-release/global-nutraceuticals-market; 3. Data Bridge Market Research, U.S. Psychedelic Drugs Market – Industry Trends and Forecast to 2027

Products
We create novel in-house formulations that help to create a healthier relationship between consumers and adult use recreational substances.

Technologies
We develop licensable technologies that improve the delivery of Biopsychoactives™ and reduce the reliance and dependency on addictive substances by preventing much of the damage these substances cause in the body.

Sciences
The integration of our expertise in Biopsychoactives™ delivery technologies, our understanding of functional medicine and our science-backed, evidence-based approach to novel fortified food and nutraceutical formulations uniquely positions us within the adult recreational intoxicants market.
Global Economic Cost of Mental Disorders
The world is in a growing mental health crisis.
Yesterday’s treatments clearly aren’t fixing the problem.

- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007565/

Much More Than Just Mental Disorder
There's also an epidemic of unhealthy & unsuccessful thinking.
It’s holding back everyday people in their work, relationships, & self-realization.
Yesterday’s treatments were never designed to address these problems at all.